Peptide protocols fail many people not because the science is wrong, but because they're built for population averages. FTO, FOXO3, ACTN3, SHBG, and COMT variants mean weight management, longevity, muscle, and hormone biology works differently in everyone. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights to reveal exactly where your biology diverges.

SNP, gene, allele, genotype, variant, pathway — six terms that appear in every genetic test report and confuse most first-time readers. The Precision Peptide Genetic Test analyzes 57 SNPs across 48 genes, delivering 14 pathways, 49 peptides, and 150+ genetic insights. This guide defines each term in plain English so your results make sense on first read.

CLIA certification is the federal standard that determines whether a genetic lab can produce results a qualified healthcare provider can actually act on. The Precision Peptide Genetic Test uses Illumina Global Screening Array genotyping at CLIA-certified labs — processing 57 SNPs across 48 genes for 150+ genetic insights. This post explains what CLIA certification requires and why the standard matters.

The Precision Peptide Genetic Test analyzes your genetic response to the pathways targeted by 49 unique compounds across five protocol families — GLP-1, growth hormone, androgens, estrogens, and vascular modulators. This post breaks down how each protocol family maps to genetic pathways, what the 49-peptide panel covers, and what your results reveal.

Genetic testing reveals tendencies, not outcomes — a FOXO3 variant doesn't predict lifespan, a slow-COMT variant doesn't diagnose any condition, an ACTN3 XX genotype doesn't cap muscle growth. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights. Understanding what DNA can and cannot tell you is the difference between informed and overconfident.

Your Precision Peptide Genetic Test report delivers 150+ insights across 14 pathways — FOXO3 for longevity, ACTN3 for muscle, COMT for methylation, and more. This guide walks through how to read pathway scores, interpret gene variants, and synthesize findings into the informed conversation every peptide protocol decision should start with.

Before committing to a peptide protocol, genetic testing reveals how your body will actually respond across GLP-1 signaling, growth hormone axis, estrogen clearance, and sexual response pathways. The Precision Peptide Genetic Test maps 14 pathways, 49 peptides, and 150+ genetic insights. Test first. Invest second. That sequence is the entire premise of precision peptide decisions.

The precision health stack is a 4-layer system: genetic testing as the foundation, blood work for state data, supplements and lifestyle for baseline support, and protocols as the intervention layer. The Precision Peptide Genetic Test anchors the stack — analyzing 14 pathways, 49 peptides, and 150+ genetic insights that shape how every layer above performs.

Genetic peptide testing analyzes how your DNA shapes 14 biological pathways that peptide protocols target — from GLP-1 signaling to growth hormone axis to estrogen clearance. The PlexusDx Precision Peptide Genetic Test delivers 150+ insights across 49 unique peptides, turning peptide decisions from guesswork into evidence-based conversations with your healthcare provider.

The Precision Peptide Genetic Test processes raw DNA through Illumina Global Screening Array genotyping, CLIA-certified lab analysis, and AI-driven pathway interpretation — transforming 57 SNPs across 48 genes into 150+ actionable insights spanning 14 pathways and 49 peptides. This post explains how that pipeline works end to end, from saliva sample to personalized genetic report.